NxStage Medical, Inc., is a medical device company, headquartered in Lawrence, Massachusetts, USA that develops, manufactures and markets innovative products for the treatment of End-Stage Renal Disease (ESRD) and acute kidney failure.
NxStage’s history is rooted in technology and research, and our groundbreaking solutions are helping to improve the lives of kidney patients across the globe. NxStage is also leading a movement to transform kidney care, and enhance patient access to home haemodialysis giving them the choice to perform their treatments at home.
Since 2013, NxStage has been selling home haemodialysis products and services directly in the United Kingdom through its subsidiary, NxStage Medical UK, Ltd. The UK team is solely dedicated to supporting home haemodialysis in the United Kingdom through customized clinical, commercial, and education support for UK centres, through programmes like the Simply Home Training Course.
The NxStage® System One is the device to help expand patience choice, and it was designed specifically to overcome the challenges of using traditional equipment at home. Its size, simplicity, portability, and flexibility help make home haemodialysis a realistic option for patients, fitting into their life and lifestyle.
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.